IgG4 Related Disease

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

IgG4 Related Disease Trial (CM310)

Not yet recruiting
  • IgG4 Related Disease
  • CM310
  • (no location specified)
Feb 13, 2023

IgG4 Related Disease Trial in United States (Obexelimab, Placebo)

Recruiting
  • IgG4 Related Disease
  • Walnut Creek, California
  • +3 more
Jan 27, 2023

COVID-19 on Clinical Outcomes and Management of IgG4 Related

Active, not recruiting
  • IgG4 Related Disease
  • Covid19
  • exposure to COVID19
  • Sha Tin, New Territories, Hong Kong
    Prince of Wales Hospital, The Chinese University of Hong Kong
Nov 18, 2022

IgG4 Related Disease Trial in Worldwide (Inebilizumab, Placebo)

Recruiting
  • IgG4 Related Disease
  • Palo Alto, California
  • +81 more
Oct 19, 2022

IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

Recruiting
  • IgG4 Related Disease
  • IgG4-RD
  • Atlanta, Georgia
  • +2 more
Jul 13, 2022